These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7644567)

  • 1. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.
    Griebel G
    Pharmacol Ther; 1995 Mar; 65(3):319-95. PubMed ID: 7644567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the effects of 5-HT-related compounds in experimental models of anxiety: evidence for multiple mechanisms of 5-HT in anxiety or never ending story?
    Griebel G
    Pol J Pharmacol; 1996; 48(2):129-36. PubMed ID: 9112642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models for anxiety and response to serotonergic drugs.
    Broekkamp CL; Berendsen HH; Jenck F; Van Delft AM
    Psychopathology; 1989; 22 Suppl 1():2-12. PubMed ID: 2567038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.
    Barrett JE; Vanover KE
    Psychopharmacology (Berl); 1993; 112(1):1-12. PubMed ID: 7870996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possible involvement of serotonin receptors in anxiety disorders].
    Matsumoto M; Yoshioka M
    Nihon Yakurigaku Zasshi; 2000 Jan; 115(1):39-44. PubMed ID: 10876814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiologic basis of anxiety and its treatment.
    Salzman C; Miyawaki EK; le Bars P; Kerrihard TN
    Harv Rev Psychiatry; 1993; 1(4):197-206. PubMed ID: 9384849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for screening anxiolytic-like drugs: a perspective.
    Bourin M
    Dialogues Clin Neurosci; 2015 Sep; 17(3):295-303. PubMed ID: 26487810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent.
    Pisu C; Pira L; Pani L
    Behav Pharmacol; 2010 Oct; 21(7):649-53. PubMed ID: 20802307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
    Kasahara K; Hashimoto S; Hattori T; Kawasaki K; Tsujita R; Nakazono O; Takao K; Kawakubo H; Nagatani T
    J Pharmacol Sci; 2015 Jan; 127(1):109-16. PubMed ID: 25704026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin agents in anxiety.
    Taylor DP
    Ann N Y Acad Sci; 1990; 600():545-56; discussion 556-7. PubMed ID: 2252334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease.
    Sun YN; Wang T; Wang Y; Han LN; Li LB; Zhang YM; Liu J
    Neuropharmacology; 2015 Aug; 95():181-91. PubMed ID: 25797491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research in anxiety disorders: from the bench to the bedside.
    Garner M; Möhler H; Stein DJ; Mueggler T; Baldwin DS
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):381-90. PubMed ID: 19327970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic profiles.
    Gershon S; Eison AS
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):45-57. PubMed ID: 6139369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic mechanisms in anxiety.
    Eison AS; Eison MS
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):47-62. PubMed ID: 8115673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.